Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10794)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2018 (publication date) through Jan 22, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Stapff MP. Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes. World J Diabetes 2018; 9(12): 252-257 [PMID: 30588287 DOI: 10.4239/wjd.v9.i12.252] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v9/i12/252.htm |
| Number | Citing Articles |
| 1 |
Taylor J. Clegg, Noor Kawmi, Nicholas M. Graziane. Different classes of antibiotics have varying effects on the risk of developing opioid use disorder: a national database study. Journal of Substance Use 2023; 28(1): 101 doi: 10.1080/14659891.2021.2010140
|
| 2 |
Brittany N Franco, Shinichi Asano. COVID-19-Related Trends and Characteristics of Type 2 Diabetes Mellitus and Metabolic Syndrome. Cureus 2022; doi: 10.7759/cureus.21483
|
| 3 |
Mario Enrico Canonico, Judith Hsia, Connie N Hess, Marc P Bonaca. Sex differences in guideline-directed medical therapy in 2021–22 among patients with peripheral artery disease. Vascular Medicine 2023; 28(3): 233 doi: 10.1177/1358863X231155308
|
| 4 |
Brandon Muncan, Alan Abboud, Aikaterini Papamanoli, Mark Jacobs, Allison J. McLarty, Hal A. Skopicki, Andreas P. Kalogeropoulos. Five-Year Cardiovascular Outcomes after Infective Endocarditis in Patients with versus without Drug Use History. Journal of Personalized Medicine 2022; 12(10): 1562 doi: 10.3390/jpm12101562
|
| 5 |
Dennis B. Campbell, David J.T. Campbell, Flora Au, Reed F. Beall, Paul E. Ronksley, Derek S. Chew, Yewande Ogundeji, Braden J. Manns, Brenda R. Hemmelgarn, Marcello Tonelli, Amity E. Quinn. Patterns and Patients’ Characteristics Associated With Use of Sodium-Glucose Cotransporter-2 Inhibitors Among Adults With Type 2 Diabetes: A Population-based Cohort Study. Canadian Journal of Diabetes 2023; 47(1): 58 doi: 10.1016/j.jcjd.2022.08.002
|
| 6 |
Kristen M. Tecson, Scott S. Shafiei. Textbook of Cardiorenal Medicine. 2021; : 315 doi: 10.1007/978-3-030-57460-4_24
|
| 7 |
Avery N. Koi, John C. Johnson, Trine L. Engebretsen, Muhammad A. Mujtaba, Alfred Scott Lea, Heather L. Stevenson, Michael L. Kueht. Precision in Immune Management: Balancing Steroid Exposure, Rejection Risk, and Infectious Outcomes in Adult Kidney Transplant Recipients. Journal of Personalized Medicine 2024; 14(11): 1106 doi: 10.3390/jpm14111106
|
| 8 |
Jesper Krogh, Carsten Hjorthøj, Søren L. Kristensen, Christian Selmer, Steen B. Haugaard. The effect of sodium‐glucose transport protein 2 inhibitors on mortality and heart failure in randomized trials versus observational studies. Diabetic Medicine 2021; 38(9) doi: 10.1111/dme.14600
|
| 9 |
Shahrzad Salmasi, Oriana H.Y. Yu, Kristian B. Filion. Editorial commentary: Potential role of SGLT2 inhibitors in the management of hypertension. Trends in Cardiovascular Medicine 2023; 33(8): 487 doi: 10.1016/j.tcm.2022.07.002
|
| 10 |
André J. Scheen. The current role of SGLT2 inhibitors in type 2 diabetes and beyond: a narrative review. Expert Review of Endocrinology & Metabolism 2023; 18(4): 271 doi: 10.1080/17446651.2023.2210673
|
| 11 |
Paul J Harrison, Sierra Luciano, Lucy Colbourne. Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study. Journal of Psychopharmacology 2020; 34(8): 848 doi: 10.1177/0269881120936501
|
| 12 |
Jacques Baillargeon, Efstathaia Polychronopoulou, Yong-Fang Kuo, Mukaila A. Raji. The Impact of Substance Use Disorder on COVID-19 Outcomes. Psychiatric Services 2021; 72(5): 578 doi: 10.1176/appi.ps.202000534
|
| 13 |
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu. Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia. Drugs & Aging 2021; 38(7): 593 doi: 10.1007/s40266-021-00863-5
|
| 14 |
Peter Shafeek, Taylor Clegg, Noor Kawmi, Sierra Luciano, Curtis Bone, Nicholas Graziane. The temporal relationship between antibiotic and opioid prescription on the risk of developing an opioid use disorder: A national database study. Journal of Addictive Diseases 2023; 41(4): 274 doi: 10.1080/10550887.2022.2108364
|
| 15 |
Emily R Pfaff, Andrew T Girvin, Davera L Gabriel, Kristin Kostka, Michele Morris, Matvey B Palchuk, Harold P Lehmann, Benjamin Amor, Mark Bissell, Katie R Bradwell, Sigfried Gold, Stephanie S Hong, Johanna Loomba, Amin Manna, Julie A McMurry, Emily Niehaus, Nabeel Qureshi, Anita Walden, Xiaohan Tanner Zhang, Richard L Zhu, Richard A Moffitt, Melissa A Haendel, Christopher G Chute, William G Adams, Shaymaa Al-Shukri, Alfred Anzalone, Ahmad Baghal, Tellen D Bennett, Elmer V Bernstam, Elmer V Bernstam, Mark M Bissell, Brian Bush, Thomas R Campion, Victor Castro, Jack Chang, Deepa D Chaudhari, Wenjin Chen, San Chu, James J Cimino, Keith A Crandall, Mark Crooks, Sara J Deakyne Davies, John DiPalazzo, David Dorr, Dan Eckrich, Sarah E Eltinge, Daniel G Fort, George Golovko, Snehil Gupta, Melissa A Haendel, Janos G Hajagos, David A Hanauer, Brett M Harnett, Ronald Horswell, Nancy Huang, Steven G Johnson, Michael Kahn, Kamil Khanipov, Curtis Kieler, Katherine Ruiz De Luzuriaga, Sarah Maidlow, Ashley Martinez, Jomol Mathew, James C McClay, Gabriel McMahan, Brian Melancon, Stephane Meystre, Lucio Miele, Hiroki Morizono, Ray Pablo, Lav Patel, Jimmy Phuong, Daniel J Popham, Claudia Pulgarin, Carlos Santos, Indra Neil Sarkar, Nancy Sazo, Soko Setoguchi, Selvin Soby, Sirisha Surampalli, Christine Suver, Uma Maheswara Reddy Vangala, Shyam Visweswaran, James von Oehsen, Kellie M Walters, Laura Wiley, David A Williams, Adrian Zai. Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative. Journal of the American Medical Informatics Association 2022; 29(4): 609 doi: 10.1093/jamia/ocab217
|
| 16 |
Robert James Trager, Shaffer R.S. Mok, Kayla J. Schlick, Jaime A. Perez, Jeffery A. Dusek. Association between radicular low back pain and constipation: a retrospective cohort study using a real-world national database. PAIN Reports 2021; 6(3): e954 doi: 10.1097/PR9.0000000000000954
|
| 17 |
David R. Riley, Hani Essa, Philip Austin, Frank Preston, Isatu Kargbo, Gema Hernández Ibarburu, Ramandeep Ghuman, Daniel J. Cuthbertson, Gregory Y. H. Lip, Uazman Alam. All‐cause mortality and cardiovascular outcomes with sodium‐glucose Co‐transporter 2 inhibitors, glucagon‐like peptide‐1 receptor agonists and with combination therapy in people with type 2 diabetes. Diabetes, Obesity and Metabolism 2023; 25(10): 2897 doi: 10.1111/dom.15185
|
| 18 |
Zachary G. Freedman, Jennifer A. Kane, Tonya S. King, Nicholas M. Graziane. The effect of prescribing antibiotics with opioids on the development of opioid use disorder: a national database study. Journal of Addictive Diseases 2022; 40(1): 62 doi: 10.1080/10550887.2021.1926889
|
| 19 |
Mario Enrico Canonico, Judith Hsia, Christopher P. Cannon, Marc P. Bonaca. Uptake of Newer Guideline-Directed Therapies in Heart Failure Patients With Diabetes or Chronic Kidney Disease. JACC: Heart Failure 2022; 10(12): 989 doi: 10.1016/j.jchf.2022.09.013
|
| 20 |
Haijiang Dai, Arwa Younis, Jude Dzevela Kong, Luca Puce, Georges Jabbour, Hong Yuan, Nicola Luigi Bragazzi. Big Data in Cardiology: State-of-Art and Future Prospects. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.844296
|
| 21 |
Ameur M. Manceur, Mike Durkin, Akshay Kharat, Brahim Bookhart, Marie-Hélène Lafeuille, Dominic Pilon, Iman Fakih, Patrick Lefebvre. Costs associated with renal and cardiovascular events among patients with type 2 diabetes mellitus and nephropathy: a cost model based on the CREDENCE clinical trial. Current Medical Research and Opinion 2020; 36(4): 563 doi: 10.1080/03007995.2019.1708285
|
| 22 |
Max Kappenstein, Nikolas von Bubnoff. Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores. Cancers 2024; 16(7): 1416 doi: 10.3390/cancers16071416
|
| 23 |
Francisco Batel-Marques, Diogo Pereira, Diogo Mendes, Carlos Alves, Ana Penedones. Effectiveness in clinical practice versus efficacy of dipeptidyl peptidase-4 inhibitors in clinical trials for type 2 diabetes: protocol for systematic review. BMJ Open 2019; 9(9): e032522 doi: 10.1136/bmjopen-2019-032522
|